Industry Update: Clinical Research Organizations
VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Clinical Research Organizations industry including recent transactions, market multiples, company performance and purchase price allocation percentages.
Industry Highlights
- In July 2024, Thermo Fisher Scientific participated in a private funding
round for CytoReason, which has developed a platform to map and
compare treatments, patient groups, and disease mechanisms. The
funding will aid in expanding CytoReason’s disease models into
additional indications and growing its molecular and clinical data with AI
capabilities. - On August 16, 2024, Audax Private Equity announced it entered into a definitive agreement to acquire the Clinical Services business of Avantor, Inc. for $650 million. The business operates 10 facilities across the US, UK, and Europe. It also maintains a global logistics and equipment services network.
